TRPV4 as a target for bladder overactivity.
Several papers published in the last 2-3 years suggest that transient receptor potential vanilloid 4 (TRPV4) channels are candidates as mechanosensors in the urinary bladder (including human) and indicate that modulation (inhibition) of these channels could represent a novel therapy for overactive bladder and storage dysfunction. The effects of only agonists on the bladder have been described up to now, although some compounds endowed with antagonistic activity were reported in the last year. Therefore, it is to be hoped that the effects of these compounds in different models of bladder overactivity will be evaluated.
Pharmaceutical R&D Division, RECORDATI S.p.A. Via Civitali 1, 20148 Milano Italy.
Patrizia
P
Angelico
Rodolfo
R
Testa